MetaPredictomics:整合临床病理、影像组学与器官组学数据预测非小细胞肺癌术后复发
本研究基于145例非小细胞肺癌患者术前PET/CT公开数据集,用深度学习分割19个受累及假定健康器官并提取影像组学特征,结合临床病理特征构建一级模型与堆叠集成Meta模型预测术后复发。临床病理模型C指数0.67,GTV影像组学与全肺、主动脉器官组学模型C指数均为0.65;前100个Meta模型C指数0.703至0.731,显著优于一级模型。
要点
- 临床病理一级模型C指数0.67,优于GTV影像组学及全肺、主动脉器官组学模型(均为0.65)。
- 12个器官组学模型C指数≥0.6,全肺与主动脉模型表现最佳。
- 前100个Meta模型C指数0.703至0.731,显著优于一级模型。
核心结论
- 整合临床病理数据、肿瘤影像组学与器官组学模型的Meta模型可显著增强非小细胞肺癌术后复发预测。
- 最大化利用医学影像中多器官数据、而非仅关注肿瘤及其邻近区域,对非小细胞肺癌复发预后具有价值。
研究设计与样本
- 基于145例非小细胞肺癌患者术前PET/CT的公开数据集,采用全自动深度学习分割模型从CT图像勾画19个受累器官(全肺与受累肺叶)及假定健康器官。
- 用PyRadiomics从大体肿瘤体积(GTV)及各分割器官提取214个特征(CT 107个、PET 107个),并构建包含临床特征、组织病理数据、基因突变状态、常规PET影像生物标志物及治疗史的临床病理特征集。
- 各特征集分别输入基于glmboost的生存时间预测机建立一级模型,其风险评分再作为输入构建堆叠集成Meta模型。
- 评估所有一级模型组合(C指数≥0.6)建立的Meta模型,采用独特3折交叉验证的平均C指数进行公平比较。
主要发现
- 临床病理模型C指数0.67,优于其他一级模型;GTV影像组学模型C指数0.65紧随其后。
- 器官组学模型中全肺与主动脉模型C指数均为0.65,共12个器官组学模型C指数≥0.6。
- Meta模型显著优于一级模型,前100个Meta模型C指数介于0.703至0.731。
- 前100个Meta模型中出现频率最高的模型为临床病理、全肺、食管、胰腺与GTV模型,频率分别为98、71、69、62、61。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-small cell lung cancer (NSCLC) is a complex disease characterized by diverse clinical, genetic, and histopathologic traits, necessitating personalized treatment approaches. While numerous biomarkers have been introduced for NSCLC prognostication, no single source of information can provide a comprehensive understanding of the disease. However, integrating biomarkers from multiple sources may offer a holistic view of the disease, enabling more accurate predictions. In this study, we present MetaPredictomics, a framework that integrates clinicopathologic data with PET/CT radiomics from the primary tumor and presumed healthy organs (referred to as "organomics") to predict postsurgical recurrence. PATIENTS AND METHODS: A fully automated deep learning-based segmentation model was employed to delineate 19 affected (whole lung and the affected lobe) and presumed healthy organs from CT images of the presurgical PET/CT scans of 145 NSCLC patients sourced from a publicly available data set. Using PyRadiomics, 214 features (107 from CT, 107 from PET) were extracted from the gross tumor volume (GTV) and each segmented organ. In addition, a clinicopathologic feature set was constructed, incorporating clinical characteristics, histopathologic data, gene mutation status, conventional PET imaging biomarkers, and patients' treatment history. GTV Radiomics, each of the organomics, and the clinicopathologic feature sets were each fed to a time-to-event prediction machine, based on glmboost, to establish first-level models. The risk scores obtained from the first-level models were then used as inputs for meta models developed using a stacked ensemble approach. Questing optimized performance, we assessed meta models established upon all combinations of first-level models with concordance index (C-index) ≥0.6. The performance of all the models was evaluated using the average C-index across a unique 3-fold cross-validation scheme for fair comparison. RESULTS: The clinicopathologic model outperformed other first-level models with a C-index of 0.67, followed closely by GTV radiomics model with C-index of 0.65. Among the organomics models, whole-lung and aorta models achieved top performance with a C-index of 0.65, while 12 organomics models achieved C-indices of ≥0.6. Meta models significantly outperformed the first-level models with the top 100 achieving C-indices between 0.703 and 0.731. The clinicopathologic, whole lung, esophagus, pancreas, and GTV models were the most frequently present models in the top 100 meta models with frequencies of 98, 71, 69, 62, and 61, respectively. CONCLUSIONS: In this study, we highlighted the value of maximizing the use of medical imaging for NSCLC recurrence prognostication by incorporating data from various organs, rather than focusing solely on the tumor and its immediate surroundings. This multisource integration proved particularly beneficial in the meta models, where combining clinicopathologic data with tumor radiomics and organomics models significantly enhanced recurrence prediction.
引用
- Amini M, Hajianfar G, Salimi Y, et al. MetaPredictomics: A Comprehensive Approach to Predict Postsurgical Non-Small Cell Lung Cancer Recurrence Using Clinicopathologic, Radiomics, and Organomics Data. Clin Nucl Med. 2025. PMID: 40902993. doi:10.1097/RLU.0000000000006086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。